DEF14A

Company

TG THERAPEUTICS, INC.

Filed

April 30, 2018

Period of Report

June 13, 2018

Accession Number

0001654954-18-004519

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →